Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000552996 | SCV000629313 | benign | Retinoblastoma | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000563507 | SCV000674706 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000563507 | SCV002530839 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-29 | criteria provided, single submitter | curation | |
Gene |
RCV002510914 | SCV002820715 | uncertain significance | not provided | 2022-07-14 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |